Clinical Trial

Mobile Application for Gastroesophageal Reflux Disease

Completed
View on ClinicalTrials.gov →
Summary
Gastroesophageal reflux disease (GERD) is a chronic condition with frequent symptom recurrence that may negatively affect sleep quality and quality of life. This randomized controlled study aims to evaluate whether a mobile application developed as a mobile application, combined with standard education and diaphragmatic breathing training, can reduce symptom recurrence and improve sleep quality and quality of life in patients with GERD. Participants will be randomly assigned to either an intervention group receiving the mobile application or a control group receiving standard education. Outcomes will be assessed using the GerdQ, Reflux Symptom Index (RSI), GERD-HRQL, and Insomnia Severity Index (ISI) at baseline, 2 weeks, 4 weeks, and 8 weeks.
Trial Details
NCT Number NCT07744815
Lead Sponsor Fooyin University
Conditions Gastroesophageal Reflux Esophagitis
Enrollment 90 participants
Start Date 2025-09-15
Primary Completion 2026-02-16 (estimated)
Study Completion 2026-02-16 (estimated)
Updated on ClinicalTrials.gov 2026-08-05